Your browser doesn't support javascript.
loading
Ischemia but no obstructive coronary artery disease: more than meets the eye.
Patel, N; Greene, N; Guynn, N; Sharma, A; Toleva, O; Mehta, P K.
Affiliation
  • Patel N; J. Willis Hurst Internal Medicine Residency Program, Emory University, Atlanta, GA, USA.
  • Greene N; Emory University School of Medicine, Atlanta, GA, USA.
  • Guynn N; J. Willis Hurst Internal Medicine Residency Program, Emory University, Atlanta, GA, USA.
  • Sharma A; Department of Internal Medicine, Grady Memorial Hospital, Atlanta, GA, USA.
  • Toleva O; Andreas Gruentzig Cardiovascular Center, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.
  • Mehta PK; Emory Women's Heart Center and Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.
Climacteric ; 27(1): 22-31, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38224068
ABSTRACT
Symptomatic women with angina are more likely to have ischemia with no obstructive coronary arteries (INOCA) compared to men. In both men and women, the finding of INOCA is not benign and is associated with adverse cardiovascular events, including myocardial infarction, heart failure and angina hospitalizations. Women with INOCA have more angina and a lower quality of life compared to men, but they are often falsely reassured because of a lack of obstructive coronary artery disease (CAD) and a perception of low risk. Coronary microvascular dysfunction (CMD) is a key pathophysiologic contributor to INOCA, and non-invasive imaging methods are used to detect impaired microvascular flow. Coronary vasospasm is another mechanism of INOCA, and can co-exist with CMD, but usually requires invasive coronary function testing (CFT) with provocation testing for a definitive diagnosis. In addition to traditional heart disease risk factors, inflammatory, hormonal and psychological risk factors that impact microvascular tone are implicated in INOCA. Treatment of risk factors and use of anti-atherosclerotic and anti-anginal medications offer benefit. Increasing awareness and early referral to specialized centers that focus on INOCA management can improve patient-oriented outcomes. However, large, randomized treatment trials to investigate the impact on major adverse cardiovascular events (MACE) are needed. In this focused review, we discuss the prevalence, pathophysiology, presentation, diagnosis and treatment of INOCA.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Myocardial Ischemia Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Climacteric Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Myocardial Ischemia Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Climacteric Year: 2024 Document type: Article